| | |||||||
| disease | |||||||
| 新闻 | |||||||
| Aligning Alzheimer Trials With Disease Demographics—From Rhetoric to Reality The last decade has seen unprecedented momentum in Alzheimer disease (AD) therapeutics. Disease-modifying drugs have moved from concept to ...
| |||||||
| |||||||
| Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients ... These COPD exacerbations have a profound impact on the lives of those with the disease, accelerating disease progression, increasing hospitalizations, ...
| |||||||
13 surprising ways GLP-1s may benefit the body, according to science - The Washington Post ... disease, and possibly heart disease, asthma and addiction. 1:05. GLP ... diseases — including Crohn's disease and severe skin and lung disorders.
| |||||||
| New Study Shows Possible Benefits of IVIG in Infants With HDFN - Hematology Advisor ... disease of the fetus and newborn (HDFN) and found that it could be ... Infectious Disease Advisor · McKnight's Home Care · McKnight's Long-term ...
| |||||||
| Higher Maternal UPF Intake Linked to Smaller Early Embryonic Growth - Rheumatology Advisor ... Disease · Crystal Arthropathies · Diseases of Bone and Cartilage · General Medicine · General Rheumatology · Infection in Rheumatic Disease ...
| |||||||
| Ustekinumab Dose Intensification Does Not Improve Remission Rates in CD ... disease control in these cases. There is some evidence that dose-intensification may help, and the approach is used commonly in practice despite ...
| |||||||
| 查看更多结果 | 修改此快讯 | |||||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment